(Reuters) Virtually all of the experts who wrote favorably about GlaxoSmithKline Plc's troubled diabetes drug Avandia had financial ties to drug makers, a finding that shows the need for reform of such relationships, U.S. researchers said on Thursday.
[Click the title, above, to post a comment.]
0 comments:
Post a Comment
Please do not give advice. We can best help each other by telling what works for us, not what we think someone else should do.